Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

Press Release Oct 9, 2020

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]

National Study Finds Lyme Disease 10 Times Greater Than Reported to CDC; Quidel-Sponsored Webinar Reveals Prevalence and Patterns of Lyme Disease

Press Release Aug 19, 2020

(SAN DIEGO, Calif. – Aug. 19, 2020) — The number of Americans afflicted with Lyme disease was found to be 10 times greater than the 30,000 cases reported each year to the Centers for Disease Control and Prevention, according to […]

Tag: Infectious Disease

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

National Study Finds Lyme Disease 10 Times Greater Than Reported to CDC; Quidel-Sponsored Webinar Reveals Prevalence and Patterns of Lyme Disease

Cookies & Privacy